Table 4.
Endpoint | Time (months) |
---|---|
Median follow-up, living patients |
11.1 |
Median survival |
10.6 |
Median local control |
41.5 |
Distant Intracranial Failure |
|
Median DIF, all patients |
17.3 |
Median DIF, progressive disease |
6.2 |
Median DIF, stable disease |
Not reached |
1-year outcomes |
% Survival |
1-year actuarial OS |
47.9% |
1-year actuarial LC |
89.1% |
1-year actuarial DIF | 61.2% |